ARTICLE | Finance

Menlo Ventures continues scaling focus on tech-enabled bio 

Menlo is looking to invest in generative AI for drug design and problem-solvers for gene editing — and to grow its healthcare team

July 11, 2023 9:30 PM UTC

Menlo Ventures is continuing to expand its healthcare focus and betting big on generative AI, where it sees data specialization, not size, as the key to success.

Menlo’s Greg Yap told BioCentury the VC is “trying to scale up our investments in the area of technology-enabled bio” by dedicating more resources to building its healthcare team and portfolio, and looking for “the relatively small number of places” where a platform technology can overcome a challenge blocking therapeutic progress...